EyePoint Pharmaceuticals, Inc.
USD14.45
+0.34 (+2.41%)
CEO
Jay S. Duker
IPO Date
2005-01-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.77
Prev. Close
$14.11
Day Low
$13.77
Day High
$14.45
52W Low
$8.96
52W High
$19.11
Market Cap
$1.21B
Volume
0.11M
| -3.2 |
| 31 Dec 2023 | FY | 89.9% | -153.8% | -26.6% | -19.9% | 0.02 | 5.45 | -12.4 |
| 31 Dec 2022 | FY | 79.9% | -247.0% | -106.1% | -56.7% | 0.48 | 5.00 | -1.3 |
| 31 Dec 2021 | FY | 77.9% | -158.1% | -31.7% | -22.2% | 0.21 | 10.05 | -6.0 |
| 31 Dec 2020 | FY | 83.1% | -131.8% | -244.8% | -49.5% | 2.21 | 4.24 | -1.9 |
| 31 Dec 2019 | FY | 86.8% | -278.9% | -681.8% | -77.8% | 6.07 | 3.62 | -2.8 |
| 30 Jun 2018 | FY | -524.9% | -1795.7% | -455.0% | -74.2% | 1.48 | 1.84 | -1.8 |
| 30 Jun 2017 | FY | 100.0% | -245.2% | -138.6% | -99.0% | 1.30 | 3.35 | -3.3 |
| 30 Jun 2016 | FY | 49.7% | -1330.1% | -103.2% | -68.1% | 0.00 | 5.88 | -4.2 |
| -5.6 |
| 30 Sept 2025 | Q3 | 25.4% | -6183.4% | -29.8% | -23.7% | 0.11 | 7.18 | -4.2 |
| 30 Jun 2025 | Q2 | 96.9% | -1114.3% | -24.2% | -19.7% | 0.09 | 8.00 | -2.8 |
| 31 Mar 2025 | Q1 | 96.7% | -184.8% | -15.1% | -12.5% | 0.08 | 7.85 | -2.1 |
| 31 Dec 2024 | Q4 | 93.0% | -357.3% | -12.3% | -9.9% | 0.06 | 7.81 | -2.9 |
| 30 Sept 2024 | Q3 | 93.0% | -279.0% | -13.4% | -9.8% | 0.10 | 5.50 | -3.7 |
| 30 Jun 2024 | Q2 | 85.2% | -325.3% | -13.5% | -9.5% | 0.10 | 4.75 | -3.6 |
| 31 Mar 2024 | Q1 | 93.5% | -250.6% | -11.7% | -8.9% | 0.02 | 5.08 | -9.2 |
| 31 Dec 2023 | Q4 | 92.9% | -100.5% | -5.3% | -4.0% | 0.02 | 5.45 | -16.8 |